Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-30 am EDT			5-day change	1st Jan Change
5,364 ^JPY	+7.07%		+15.03%	+38.53%

07:01am	Remsons, Daiichi Infotainments Form Joint Venture	MT
Apr. 29	AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Remsons, Daiichi Infotainments Form Joint Venture	01:01am
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement	Apr. 29
AstraZeneca makes progress with Truqap and Enhertu cancer treatments	Apr. 29
AstraZeneca's Breast Cancer Drug Improves Progression-free Survival in Late-stage Study	Apr. 29
Hipgnosis Songs Fund backs new Blackstone bid	Apr. 29
Scholz sichert Pharmabranche weiter Unterstützung zu	Apr. 25
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	Apr. 25
Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	Apr. 25
AstraZeneca upbeat as cancer drugs underpin sales growth	Apr. 25
Le marché devient un peu timbré	Apr. 25
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	Apr. 25
Daiichi Sankyo Company, Limited announces an Equity Buyback for 55,000,000 shares, representing 2.87% for ¥200,000 million.	Apr. 25
Daiichi Sankyo Company, Limited authorizes a Buyback Plan.	Apr. 24
Pharmabranche erwartet Aufschwung - Standort Deutschland zunehmend gefragt	Apr. 24
Japon: le rejet en mer d'eau de Fukushima interrompu après un incident	Apr. 24
Middle East Tensions Dent Asian Stock Markets	Apr. 19
Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark	Apr. 10
Roche erhält CE-Kennung für erstes Brustkrebs-Begleitdiagnostikum	Apr. 10
Scholz setzt auf weitere Pharma-Investitionen in Deutschland	Apr. 08
AstraZeneca's Enhertu Receives FDA Approval for HER2-Positive Solid Tumor Indication	Apr. 08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Daiichi Sankyo Co., Ltd.

Equities

4568

JP3475350009

Other languages

Filters